Skip to main content
. 2017 Mar 6;8(13):22059–22075. doi: 10.18632/oncotarget.15908

Figure 5. PRDX5 knockdown results in growth inhibition of gastric cancer cell line.

Figure 5

PRDX5 knockdown as measured by quantitative reverse-transcription PCR (A) and western blot (B). Label-free real-time quantitative monitoring (C) of cell index over 48 h for SGC7901 cells with shRNAs against PRDX5 (Green) or negative controls (Red). The levels of protein carbonyl contents were measured in PRDX5 knockdown cells (D). The Bcl-2 and Caspase-3 were examined through Western blots (E).